Losing items doesn’t always indicate poor memory … 15 generics saved Medicare about $15 billion from 2015 to 2021 … Healthy lifestyle could offset life-shortening genes … EHR tool combats health...
Doctor sounds alarm on quality, efficacy of Alzheimer’s supplement
By
Kristen Fischer
Feb 27, 2024
When it was sold as a prescription generic drug, galantamine was labeled accurately and it wasn’t contaminated. But that wasn’t the case when galantamine was sold as an over-the-counter dietary supplement,...
Clinical briefs for Monday, Feb. 26
By
Kristen Fischer
Feb 26, 2024
2023 pharma CEO salaries revealed … Biomarkers can spot changes 20 years prior to Alzheimer’s diagnosis … Headset plays part in physical therapy for people with Parkinson’s disease … Medicare...
Excess niacin may be bad for your heart
By
Kristen Fischer
Feb 21, 2024
Too much of the B vitamin niacin can increase inflammation and damage blood vessels, according to a study published Monday in Nature Medicine.
Clinical briefs for Monday, Feb. 5
By
Kristen Fischer
Feb 05, 2024
Dementia was rare in ancient times … 4 US sites join Parkinson’s disease genetics study… Risvodetinib phase 1 results for Parkinson’s promising … Disparities have a say in stroke recovery …...
Genetics, air pollution can boost Parkinson’s risk, study finds
By
Kristen Fischer
Jan 26, 2024
The idea that air pollution can play a role in the development of Parkinson’s disease has been in the news in recent years, and a new study adds to evidence of the association.
Clinical briefs for Friday, Jan. 26
By
Kristen Fischer
Jan 26, 2024
Exam can spot glaucoma risk in primary angle-closure suspect patients … Heart organization announces $7.8M for “food is medicine” research … Researchers eye gene in heart failure that may guide...
Clinical briefs for Friday, Jan. 19
By
Kristen Fischer
Jan 19, 2024
Large-scale study of those of African descent spots genetic variants tied to glaucoma … Brain stimulation kept quality of life stable after 5 years in people with Alzheimer’s … Insurers must apply...
Race, ethnicity help determine which controllable risk factors for dementia have biggest impacts
By
Kristen Fischer
Jan 18, 2024
Controllable risk factors that factor into Alzheimer’s or dementia cases play varying roles based on someone’s race and ethnicity, a new study shows.
Researchers spot whose cognitive ability may shift during dementia trials
By
Kristen Fischer
Jan 17, 2024
People who changed cognitive status from impaired to normal during clinical trials tend to be younger, have better cognition and be negative for amyloid biomarkers, according to a new study.